Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma, Synovial 1Sarcoma, Myeloid 1Sarcoma 1Rhabdoid Tumor 1Neurofibrosarcoma 1Myeloproliferative Disorders 1Liposarcoma 1Leukemia, Myeloid, Acute 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Fibrosarcoma 1Dermatofibrosarcoma 1Central Nervous System Neoplasms 1Blast Crisis 1

Interventions

Radiotherapy 4Doxorubicin 4pazopanib 2Sunitinib 2Radiation Dose Hypofractionation 2Ifosfamide 2selinexor 1ribociclib 1pegfilgrastim 1lentiviral minigene vaccine of COVID-19 coronavirus 1Vinorelbine 1Topotecan 1Thiotepa 1Surgical Procedures, Operative 1Razoxane 1Radiotherapy, Intensity-Modulated 1Proton Therapy 1Polymerase Chain Reaction 1Paclitaxel 1Nivolumab 1Neoadjuvant Therapy 1Gene Expression Profiling 1Gemcitabine 1Fluorodeoxyglucose F18 1Filgrastim 1Estramustine 1Diathermy 1Dexrazoxane 1Cyproheptadine 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Fibrosarcoma × Razoxane × Clear all
NCT02584309 2023-11-07

Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma

Washington University School of Medicine

Phase 2 Completed
73 enrolled 11 charts
Sarcoma

Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Synovial, Dermatofibrosarcoma, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡